Xu Deng

1.6k total citations
70 papers, 1.2k citations indexed

About

Xu Deng is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Xu Deng has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 24 papers in Organic Chemistry and 8 papers in Biochemistry. Recurrent topics in Xu Deng's work include Catalytic C–H Functionalization Methods (12 papers), Cyclopropane Reaction Mechanisms (6 papers) and Superconducting Materials and Applications (6 papers). Xu Deng is often cited by papers focused on Catalytic C–H Functionalization Methods (12 papers), Cyclopropane Reaction Mechanisms (6 papers) and Superconducting Materials and Applications (6 papers). Xu Deng collaborates with scholars based in China, United States and United Kingdom. Xu Deng's co-authors include Qin‐Shi Zhao, Chengfeng Xia, Xiaogang Tong, Dashan Li, Yingjun Zhou, Guangyao Zeng, Wei Cao, Ming Ding, Kangjiang Liang and Li‐Yan Peng and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Xu Deng

65 papers receiving 1.2k citations

Peers

Xu Deng

PHARM

Demin Zhou Japan

Kozo Shibata Japan

Ronald C. Crouch United States

Toshiyuki Akiyama Japan

Alexandr Jegorov Czechia

Tôru Okuda Japan

Yoshi Yamano Japan

Mark O’Neil-Johnson United States

Philip J. Sidebottom United Kingdom

Gavin J. Williams United States

Demin Zhou Japan

Xu Deng

192 ×0.4

1.0k ×2.3

88 ×0.5

109 ×0.7

PHARM

237 ×2.1

PHARM

Citations per year, relative to Xu Deng Xu Deng (= 1×) peers Demin Zhou

Countries citing papers authored by Xu Deng

Since Specialization

Citations

This map shows the geographic impact of Xu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Deng more than expected).

Fields of papers citing papers by Xu Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Deng. The network helps show where Xu Deng may publish in the future.

Co-authorship network of co-authors of Xu Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Deng. A scholar is included among the top collaborators of Xu Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Deng. Xu Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, Xu, et al.. (2025). Experimental and numerical study on the soil arching effect caused by deep-buried shield tunneling. Underground Space. 24. 129–141.

Liu, Yan‐Yun, Yuancheng Zhou, Peng Zhan, et al.. (2025). TCM theory-inspired discovery of DNJ-flavonoid conjugates as broad-spectrum anti-SARS-CoV-2 agents by primarily targeting ER-associated glycoprotein folding process. European Journal of Medicinal Chemistry. 290. 117582–117582.

Peng, Lian‐Mao, et al.. (2025). A Dehydrogenative Diels–Alder/Aromatization Sequence to Access 6/6/6/6/5 Pentacyclic Steroids: Their Anti-inflammatory Activities. Organic Letters. 27(6). 1335–1339.

Liu, Sixu, Yuzheng Zhou, Yuqing Zhou, et al.. (2024). Discovery of meisoindigo derivatives as noncovalent and orally available Mpro inhibitors: their therapeutic implications in the treatment of COVID-19. European Journal of Medicinal Chemistry. 273. 116498–116498. 3 indexed citations

Liu, Yan‐Yun, et al.. (2024). Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments. Natural Products and Bioprospecting. 14(1). 55–55. 3 indexed citations

Wang, Min, et al.. (2024). The transcription factor PPARA mediates SIRT1 regulation of NCOR1 to protect damaged heart cells. Cardiovascular Diagnosis and Therapy. 14(5). 832–847. 1 indexed citations

Chen, Ling, Xu Deng, Tian Guang, et al.. (2024). Design, Synthesis, and Biological Activity of Novel Quinone Derivatives as Potent STAT3 Inhibitors for Psoriasis Treatment. Journal of Medicinal Chemistry. 67(17). 15438–15455. 2 indexed citations

Deng, Xu, Suling Huang, Jian Ren, et al.. (2022). Development and structure–activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors. Natural Products and Bioprospecting. 12(1). 36–36. 6 indexed citations

Hua, Xiaohui, Xu Deng, Jiheng Xu, et al.. (2019). The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein. Cell Death and Differentiation. 27(2). 632–645. 21 indexed citations

10.

Chen, Lan, Wei Cao, Guangyao Zeng, et al.. (2019). Dual-targeting Rutaecarpine-NO donor hybrids as novel anti-hypertensive agents by promoting release of CGRP. European Journal of Medicinal Chemistry. 168. 146–153. 35 indexed citations

11.

Deng, Xu, Liyang Shi, Yuqing Guan, et al.. (2019). Enantioselective Rhodium-Catalyzed Cycloisomerization of 1,6-Allenynes to access 5/6-Fused Bicycle[4.3.0]nonadienes. Nature Communications. 10(1). 949–949. 24 indexed citations

12.

Hua, Xiaohui, Jiheng Xu, Xu Deng, et al.. (2018). New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating Sestrin-2 in human bladder cancer. Cancer Letters. 436. 38–51. 38 indexed citations

13.

Zhang, Mudan, Xu Deng, Xinmeng Guan, et al.. (2018). Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4+ T Cell Migration and Is Regulated by the Viral Immediate-Early Protein ICP4. Frontiers in Immunology. 9. 2932–2932. 16 indexed citations

14.

Wang, Ping, Kai Hu, Sukun Luo, et al.. (2015). DC-SIGN as an attachment factor mediates Japanese encephalitis virus infection of human dendritic cells via interaction with a single high-mannose residue of viral E glycoprotein. Virology. 488. 108–119. 50 indexed citations

15.

Sheikh, Md Sayed Ali, Zhenyu Zhao, Fei Li, et al.. (2014). Serum Lectin-Like Oxidized-Low Density Lipoprotein Receptor-1 and Adiponectin Levels Are Associated With Coronary Artery Disease Accompanied With Metabolic Syndrome. Iranian Red Crescent Medical Journal. 16(8). e12106–e12106. 8 indexed citations

16.

Yang, Xing‐Wei, Xu Deng, Xia Liu, et al.. (2012). Hypercohin A, a new polycyclic polyprenylated acylphloroglucinol possessing an unusual bicyclo[5.3.1]hendecane core from Hypericum cohaerens. Chemical Communications. 48(48). 5998–5998. 55 indexed citations

17.

Xu, Gang, Xing‐Wei Yang, Chunyan Wu, et al.. (2012). Przewalskone: a cytotoxic adduct of a danshenol type terpenoid and an icetexane diterpenoid via hetero-Diels–Alder reaction from Salvia przewalskii. Chemical Communications. 48(37). 4438–4438. 29 indexed citations

18.

Dong, Liao‐Bin, Jing Yang, Juan He, et al.. (2012). Lycopalhine A, a novel sterically congested Lycopodium alkaloid with an unprecedented skeleton from Palhinhaea cernua. Chemical Communications. 48(72). 9038–9038. 45 indexed citations

19.

Deng, Xu, Jia Su, Yu Zhao, et al.. (2011). Development of novel conformation-constrained cytotoxic derivatives of cheliensisin A by embedment of small heterocycles. European Journal of Medicinal Chemistry. 46(9). 4238–4244. 12 indexed citations

20.

Deng, Xu. (2008). Effects of extracts from venenum bufonis with different solvents on immunocyte functions of mice in vitro. Zhongguo yaolixue yu dulixue zazhi. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact